[1]
吴颖运, 洪坤学, 耿运琪, 邵一鸣, 2004: The Application of Live Attenuated SHIV in AIDS Vaccine Research, Virologica Sinica, 19, 187-191.
[2]
Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, He Huang, Jianwei Wang, Zhendong Zhao, 2021: Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation, Virologica Sinica, 36, 890-900. doi: 10.1007/s12250-021-00369-9
[3]
蒋岩, 1997: Research advances of animal models of murine AIDS for evaluation of anti - AIDS treatment, Virologica Sinica, 12, 1-.
[4]
Yi-ming SHAO, 2007: AIDS Research and Its Role in China's AIDS Prevention and Control Policies, Virologica Sinica, 22, 421-423.
[5]
朱义鑫, 刘畅, 乔文涛, 陈启民, 耿运琪, 曾毅, 2005: Construction and Characterization of SHIV Carrying HIV-1 Capsid, Virologica Sinica, 20, 346-351.
[6]
Susan L. Uprichard, 2010: Hepatitis C Virus Experimental Model Systems and Antiviral drug Research^*, Virologica Sinica, 25, 227-245. doi: 10.1007/s12250-010-3134-0
[7]
陆宇, 陈建国, 丁明孝, 1996: Research progress on hog cholera virus and its vaccine, Virologica Sinica, 11, 201-.
[8]
卢曾军, 曹轶梅, 刘在新*, 谢庆阁, 2006: Advance of Adenoviral Vector in Gene Therapy and Vaccine Research, Virologica Sinica, 21, 622-626.
[9]
郑永唐, 贲昆龙, 王金焕, 齐瑾, 黄生民, 1997: Establishment and application of an experimental model for screening anti - AIDS drugs with simian type D retrovirus, Virologica Sinica, 12, 61-.
[10]
Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9
[11]
寸韡, 刘龙丁, 张莹, 罗杰, 吴文娟, 张雪梅, 廖芸, 李琦涵*, 2006: Construction and Application of Eukaryotic Expression Vector phIE Containing HSVI α-gene Promoter, Virologica Sinica, 21, 328-323.
[12]
李宏玲, 李河民, 俞永新, 严子林, 1990: Application of Plaque Assay Method for Rabies Virus in the Study of Virus and Vaccine, Virologica Sinica, 5, 135-.
[13]
李建娜, 向开军, 周荣, 丁勇强, 白培胜, 张裕平, 朱冰, 曾其毅, 2005: Expression of SARS Coronavirus Membrane Protein and its DNA Vaccine Construction, Virologica Sinica, 20, 113-116.
[14]
尚大庄, 王永祥, 王玉坤, 顾葆良, 1989: Experimental Research and Application of Polyacrylamide Gel Debris Absorption and Elution Method for Virus Concentration, Virologica Sinica, 4, 199-.
[15]
李萍, 严家新, 朱家鸿, 1997: Research on DNA vaccine carrying the rabies virus glycoprotien gene and its immune protection effects, Virologica Sinica, 12, 142-.
[16]
Shuting Huo, Changcheng Wu, Zhenyong Qi, Jiewei Sun, Xin Meng, Jingdong Song, Zhongxian Zhang, Liye Jin, Chang Shu, Zhifeng Lin, Weibang Huo, Yao Deng, Li Zhao, Jiandong Li, Wenjie Tan, 2025: Identification of a novel ectromelia virus from rodent: Implications for use as an in vivo infection model for vaccine and antiviral research, Virologica Sinica, 40, 601-612. doi: 10.1016/j.virs.2025.07.001
[17]
沈弢, 张晓燕, 南昌龙, 童骁, 范秀娟, 沈荣显, 邵一鸣, 2005: Construction and Characterization of EIAV Vaccine Infectious Clones Labeled with FLAGTM or 6 His-tag, Virologica Sinica, 20, 257-261.
[18]
余兴龙, 涂长春, 李红卫, 陈创夫, 李作生, 马正海, 孙明, 殷震, 2000: Construction of Enkaryotie Expression Plasm ids of CSFV E2 Gene and the Study on DNA Vaccine, Virologica Sinica, 15, 264-271.
[19]
姬向波, 刘文波, 魏建超, 牛明福, 周斌, 曹瑞兵, 陈溥言*, 2006: Construction and Immune Effect of the Recombinant DNA Vaccine Expressing ILTV Major Antigen Epitope gene, Virologica Sinica, 21, 481-484.
[20]
Yi ZENG, 2007: Strategy for AIDS Prevention and Treatment, Virologica Sinica, 22, 419-420.